The prevalence of the metabolic syndrome in patients with schizoaffective disorder - bipolar subtype
The prevalence of the metabolic syndrome in patients with schizoaffective disorder - bipolar subtype
复制标题
DOI：
10.1111/j.1399-5618.2004.00126.x
复制
发表时间：
2004-08-01
影响因子：
5.4
通讯作者：
Kupfer, DJ
中科院分区：
文献类型：
--
作者：
Basu, R;Brar, JS;Kupfer, DJ
目的：评估双相情感障碍患者代谢综合征的时点患病率。方法：对正在进行的托吡酯治疗双相情感障碍的临床试验的参与者进行基线代谢综合征的时点患病率评估。代谢综合征的标准包括：（a）男性腰围> 102 cm（40英寸），或女性腰围> 88 cm（35英寸）;（B）空腹血清甘油三酯水平大于或等于150 mg/dL;（c）空腹高密度脂蛋白（HDL）胆固醇水平大于或等于150 mg/dL;（d）空腹高密度脂蛋白（HDL）胆固醇水平大于或等于150 mg/dL。
Objectives: To evaluate the point prevalence of the metabolic syndrome in patients with schizoaffective disorder - bipolar type.Methods: Consenting patients who were participants in an ongoing clinical trial of adjunctive topiramate treatment for schizoaffective disorder, bipolar type were evaluated at baseline for the point prevalence of the metabolic syndrome. The criteria for the metabolic syndrome included: (a) waist circumference > 102 cm (40 inches) in males, or > 88 cm (35 inches) in females; (b) fasting serum triglyceride levels greater than or equal to 150 mg/dL; (c) fasting high density lipoproteins (HDL) cholesterol